Dermoplast Kids Spray
NDC Package 16864-660-01
Package Information
Dermoplast Kids (benzethonium chloride and benzocaine) sprays is clean the affected areaAdults and children 2 years of age and olderapply a small amount to affected area 1 to 3 times dailyChildren under 2 years of ageconsult a doctorto use this product, hold the can 6 to 12 inches away from the affected area. This formulation utilizes a spray delivery system. Marketed by Advantice Health, Llc., this product is identified by NDC 16864-660 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 2609039 - benzethonium chloride 0.2 % / benzocaine 15 % Topical Spray
- RxCUI: 2609039 - benzethonium chloride 2 MG/ML / benzocaine 150 MG/ML Topical Spray
- RxCUI: 2627727 - Dermoplast Antiseptic Kids 0.2 % / 15 % Topical Spray
- RxCUI: 2627727 - benzethonium chloride 2 MG/ML / benzocaine 150 MG/ML Topical Spray [Dermoplast Antibacterial]
- RxCUI: 2627727 - Dermoplast Antibacterial Kids (benzethonium chloride 0.2 % / benzocaine 15 % ) Topical Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16864 - Advantice Health, Llc.
- 16864-660 - Dermoplast Kids
- 16864-660-01 - 57 g in 1 CAN
- 16864-660 - Dermoplast Kids
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16864-660-01 identifies a specific commercial package of 57 g in 1 can of Dermoplast Kids First Aid, a human over the counter drug labeled by Advantice Health, Llc.. This spray is formulated for topical use and contains benzethonium chloride; benzocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advantice Health, Llc. on March 01, 2022. The current certification is valid through December 31, 2026.
How is this Advantice Health, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16864066001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.